Viewing 0 reply threads
  • Author
    • #13765
      Dagmar Munn

        The webinar will review edaravone evidence, talk about the use of biomarkers to understand the effect of medical therapies, present the design of the REFINE-ALS study, and discuss how people can get involved in the study.

        REFINE-ALS: A Much-Needed Biomarker Study of Edaravone (Radicava) in ALS

        James D. Berry, MD, MPH, Massachusetts General Hospital

        Thursday, November 14, 2019  

            4:00 – 5:00 PM EST

        Register/watch webinar here.

        Note: if you miss the webinar, we will post a link to the replay once it is available.




    Viewing 0 reply threads
    • You must be logged in to reply to this topic.

    ©2023 KLEO Template a premium and multipurpose theme from Seventh Queen


    We're not around right now. But you can send us an email and we'll get back to you, asap.


    Log in with your credentials


    Forgot your details?

    Create Account